1097721-66-8

Basic information

• Product Name: 2-(2,6-dibromophenyl)-3-(4-methyl-6-trifluoromethylpyrimidin-2-yl)thiazolidin-4-one
• Synonyms: 2-(2,6-dibromophenyl)-3-(4-methyl-6-trifluoromethylpyrimidin-2-yl)thiazolidin-4-one
• CAS NO: 1097721-66-8
• Molecular Weight: 497.133
• Mol File: 1097721-66-8.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(2,6-dibromophenyl)-3-(4-methyl-6-trifluoromethylpyrimidin-2-yl)thiazolidin-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2,6-dibromophenyl)-3-(4-methyl-6-trifluoromethylpyrimidin-2-yl)thiazolidin-4-one(1097721-66-8)
• EPA Substance Registry System: 2-(2,6-dibromophenyl)-3-(4-methyl-6-trifluoromethylpyrimidin-2-yl)thiazolidin-4-one(1097721-66-8)

Safety Data

• Hazardous Substances Data: 1097721-66-8(Hazardous Substances Data)

Upstream product

• 67713-23-9 2,6-dibromobenzaldehyde 
• 68-11-1 mercaptoacetic acid 
• 5734-63-4 2-amino-6-methyl-4-(trifluoromethyl)pyrimidine 

Relevant articles and documents

Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents

A series of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones were designed, synthesized and evaluated as selective human immunodeficiency virus type-1 reverse transcriptase (HIV-1 RT) enzyme inhibitors. The results of the HIV-1 RT kit and in vitro cell based assay showed that eight compounds effectively inhibited HIV-1 replication at 20-320 nM concentrations with minimal cytotoxicity in MT-4 as well as in CEM cells.